ArticleAnnals of medicine and surgery (2012)2025

Elafibranor for primary biliary cholangitis: a dual PPAR agonist changing the treatment landscape.

Shiza Abid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.